High-dose immunoglobulin therapy in renal transplant recipients with hemophagocytic histiocytic syndrome

Journal of Nephrology

Volumn 19, Issue 3, 2006, Pages 322-326

  Asci, Gulay ^a   Toz, H ^a   Ozkahya, M ^a   Cagirgan, S ^a   Duman, S ^a   Sezis, S ^a   Ok, E ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOLOGIC FACTOR;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG MEGADOSE; FEMALE; HEMOPHAGOCYTIC HISTIOCYTIC SYNDROME; HEMOPHAGOCYTIC SYNDROME; HUMAN; KIDNEY TRANSPLANTATION; MALE; PREVALENCE; TUBERCULOSIS; DOSE RESPONSE; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; KIDNEY TRANSPLANTATION; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33749072026     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Risdall RJ, McKenna RW, Nesbit ME, Krivit W, Balfour HH, Simmons RL, Brunning RD. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979; 44: 993-1002.
2. Sato M, Matsushima T, Takada S, Hatsumi N, Kim K, Sakuraya M, Saito T, Tamura J, Karasawa M, Murakami H, Naruse T. Fulminant, CMV-associated, haemophagocytic syndrome following unrelated bone marrow transplantation. Bone Marrow Transplant 1998; 22: 1219-22.
3. Grateau G, Bachmeyer C, Blanche P, Jouanne M, Tulliez M, Galland C, Sicard D, Sereni D. Haemophagocytic syndrome in patients infected with the human immunodeficiency virus: nine cases and a review. J Infect 1997; 34: 219-25.
4. Undar L, Karpuzoglu G, Karado?an I, Gelen T, Artvinli M. Tuberculosis-associated haemophagocytic syndrome: report of two cases and a review of the literature. Acta Haematol 1996; 96: 73-8.
5. Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection- and malignancy-associated hemophagocytic syndromes. Hematol Oncol Clin North Am 1998; 12: 435-44.
6. Kürşat S, Çaǧirgan S, Ok E. Haemophagocytic-histiocytic syndrome in renal transplantation. Nephrology Dial Transplant 1997; 12: 1058-60.
7. Gill DS, Spencer A, Cobcroft RG. High-dose gamma-globulin therapy in the reactive haemophagocytic syndrome. Br J Haematol 1994; 88: 204-6.
8. Goulder P, Seward D. Intravenous immunoglobulin in virus associated hemophagocytic syndrome. Arch Dis Child 1990; 65: 1275-7.
9. Chen RL, Lin KH. Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis. Br J Haematol 1995; 89: 282-90.
10. Sullivan JL, Woda BA, Herrod HG, Koh G, Rivera FP, Mulder C. Epstein-barr virus-associated hemophagocytic syndrome: virological and immunopathological studies. Blood 1985; 65: 1097-1104.
11. Fujiwara F, Hibi S, Imashuku S. Hypercytokinemia in hemophagocytic syndrome. Am J Paediatr Hematol Oncol 1993; 15: 92-8.
12. Newland AC. The use and mechanism of action of intravenous immunoglobulin. Br J Haematol 1989; 72: 301-3.
13. Calonge VM, Glotz D, Bouscary D, Duboust A, Bruneval P, Druet P, Diebold J, Nochy D. Hemophagocytic histiocytosis in renal transplant recipients under ciclosporin therapy: report of the first two cases. Clin Transplant 1995; 9: 88-91.
14. Tsuda H. The use of cyclosporin-A in the treatment of virus-associated hemophagocytic syndromes in adults. Leuk Lymphoma 1997; 28: 73-82.